Calumet, Inc. /DE
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
CLMT$34.91-3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance Sheets
| | | | | | | |
|---|---|---|---|---|---|---|
| · · March 31, 2026 · · December 31, 2025 | ||||||
| | | (In millions, except share data) | ||||
| ASSETS | | | | | | |
| Current assets: | | | | | | |
| Cash and cash equivalents | | $138.6 | | $125.1 | ||
| Restricted cash | | 40.0 | | 80.0 | ||
| Accounts receivable, less allowance for credit losses of $1.6 and $1.1, respectively | | 358.4 | | 232.5 | ||
| Inventories | | 369.5 | | 385.2 | ||
| Derivative assets | | | — | | | 6.7 |
| Prepaid expenses and other current assets | | 21.4 | | 28.3 | ||
| Total current assets | | 927.9 | | 857.8 | ||
| Property, plant and equipment, net | | 1,336.4 | | 1,353.0 | ||
| Other noncurrent assets, net | | 490.7 | | 478.1 | ||
| Total assets | | $2,755.0 | | $2,688.9 | ||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
| Current liabilities: | | | | | ||
| Accounts payable | | $353.3 | | $281.5 | ||
| Accrued interest payable | | 27.8 | | 46.1 | ||
| Accrued salaries, wages and benefits | | 90.7 | | 84.6 | ||
| Current portion of RINs obligation | | 316.7 | | 169.3 | ||
| Derivative liabilities | | 50.0 | | — | ||
| Other current liabilities | | 92.0 | | 103.0 | ||
| Current portion of long-term debt | | 32.6 | | 156.2 | ||
| Total current liabilities | | 963.1 | | 840.7 | ||
| Other long-term liabilities | | 285.1 | | 258.0 | ||
| Long-term debt, less current portion | | 2,299.4 | | 2,077.3 | ||
| Total liabilities | | $3,547.6 | | $3,176.0 | ||
| Commitments and contingencies | | | | | ||
| Redeemable noncontrolling interest and other equity instruments | | $250.6 | | $245.6 | ||
| Stockholders' equity: | | | | | ||
| Common stock: par value $0.01 per share, 700,000,000 shares authorized, and 87,040,558 and 86,776,552 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | | $0.9 | | $0.9 | ||
| Additional paid-in capital | | | 845.3 | | | 838.8 |
| Warrants: 2,000,000 warrants issued and outstanding as of March 31, 2026 and December 31, 2025. | | | 7.8 | | | 7.8 |
| Accumulated deficit | | (1,890.4) | | (1,573.4) | ||
| Accumulated other comprehensive loss | | (6.8) | | (6.8) | ||
| Total stockholders' equity | | (1,043.2) | | (732.7) | ||
| Total liabilities and stockholders' equity | | $2,755.0 | | $2,688.9 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.